Publicacións (96) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

filter_list Internal Medicine

2025

  1. A 28-Year Multicenter Cohort Study of Nontuberculous Mycobacterial Lymphadenitis in Children, Spain

    Emerging Infectious Diseases, Vol. 31, Núm. 3, pp. 536-546

  2. A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia

    iScience, Vol. 28, Núm. 2

  3. Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)” [Vaccine 41 (2023) 3387–3398, (S0264410X23004280), (10.1016/j.vaccine.2023.04.036)]

    Vaccine

2024

  1. A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants

    Journal of Infectious Diseases, Vol. 229, pp. S112-S119

  2. Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection

    Journal of Infectious Diseases, Vol. 229, pp. S100-S111

  3. Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  4. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 78, Núm. 6, pp. 1732-1744

  5. Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))

    Archivos de Bronconeumologia

  6. External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children

    Archives of Disease in Childhood, Vol. 109, Núm. 1, pp. 58-66

  7. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

  8. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 565-575

  9. Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study

    American Journal of Respiratory and Critical Care Medicine, Vol. 210, Núm. 8, pp. 994-1001

  10. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

    Journal of Infectious Diseases

  11. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

    Nature Communications, Vol. 15, Núm. 1

  12. The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children

    Cell Reports Medicine, Vol. 5, Núm. 12

2023

  1. Addressing influenza’s underestimated burden – Iberian experts call to action

    BMC Infectious Diseases

  2. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  3. Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 49

  4. Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens

    iScience, Vol. 26, Núm. 8

  5. Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

    Antiviral research, Vol. 220, pp. 105760